BlossomHill Therapeutics to present at RAS summit and H.C. Wainwright conference
BlossomHill Therapeutics, Inc. said it will present at the 8th Annual RAS-Targeted Drug Development Summit and the H.C. Wainwright 28th Annual Global Investment Conference.
SAN DIEGO, Sept.
03, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc.
NASDAQ:BLSM, a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines for the treatment of cancer, today announced that it will…